Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Completed

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

NCT01954979

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

NCT03207958

Conditions: Graft vs Host Disease, Graft-versus-host-disease, Immune System Diseases
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

NCT02891603

Conditions: GVHD, Graft vs Host Disease, Immune System Diseases
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

NCT03605927

Conditions: GVHD, GVHD, Acute, Graft vs Host Disease, +2 more
Locations: City of Hope Cancer Center Duarte, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Evaluation of the Impact of Reduced Immunosuppression

NCT05238155

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: Methodist Dallas Medical Center Dallas, Texas, United States

View Trial Details

Completed

Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)

NCT07469865

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +18 more
Locations: Ghent University Hospital Ghent, Oost-Vlaanderen, Belgium

View Trial Details

Completed

Complement and Graft-versus-host Disease

NCT01520623

Conditions: Allografted With Myeloablative Conditioning, Graft vs Host Disease, Immune System Diseases
Locations: Saint Louis Hospital Paris, France

Saint Antoine Hospital Paris, France

Necker Hospital Paris, France

View Trial Details

Completed

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

NCT02867384

Conditions: Graft vs Host Disease, Graft vs. Host Disease, Immune System Diseases
Locations: Stanford University Palo Alto, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases

NCT05544448

Conditions: Acquired Bone Marrow Aplasia, Alopecia, Arthritis, +43 more
Locations: Hôpital Henri Mondor, 1 rue Gustave Eiffel, Créteil, Île-de-France Region, France

View Trial Details

Completed

Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT

NCT07319000

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Immune System Diseases
Locations: Hospital Universitario de Monterrey Monterrey, Mexico

View Trial Details

Graft vs Host Disease

Graft vs Host Disease trial results

Related conditions